NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM787941 Query DataSets for GSM787941
Status Public on Sep 01, 2011
Title Donor 1, Ebola infected 1hr
Sample type RNA
 
Source name Ebola-infected macrophages harvested at 1h post-treatment from donor 1
Organism Homo sapiens
Characteristics cells: Differentiated macrophages
disease state: Ebola infected
post-treatment: 1h
donor: 1
Treatment protocol Cells were infected with either mock virus preparation or ZEBOV at a multiplicity of infection (MOI) of 10.
Growth protocol Cells were cultivated in RPMI 1640 (Invitrogen, Carlsbad, CA) containing 20% heat-inactivated human AB serum (Sigma-Aldrich, St. Louis, MO), penicillin (100 U/ml), streptomycin (100 µg/ml), and L-glutamine (2 mM); cells were incubated at 37 ºC in a humidified 5% CO2 environment
Extracted molecule total RNA
Extraction protocol Cell supernatants were removed from the cells 1 h or 6 h post infection, and RNA from cells was purified using the RNeasy Mini Kit (QIAGEN, Valencia, CA) according to the manufacturer's instructions.
Label biotin
Label protocol Using 5 µg of total RNA as input, messenger RNA was amplified and labeled in two steps. In the first step, mRNA was converted to double-stranded cDNA using Superscript Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA) and an oligo-dT primer linked to a T7 RNA polymerase binding site sequence (IDT, Coralville, IA). Double-stranded cDNA was purified by phenol-chloroform-isoamyl alcohol extraction and a standard ethanol precipitation. In the second step, the cDNA was converted to labeled cRNA (the target) using T7 RNA polymerase in the presence of biotinylated UTP and CTP (Enzo, Farmingdale, NY). Unincorporated nucleotides were removed using the RNeasy Mini kit (Qiagen) and was followed by an ethanol precipitation of the labeled target. The target was fragmented to produce a uniform distribution of short cRNAs. 10µg each of fragmented target was combined with hybridization control oligomer (Affymetrix, Santa Clara, CA) and control cRNAs (1.5pM BioB, 5.0pM BioC, 25pM BioD, and 100pM Cre; Affymetrix, Santa Clara, CA), in hybridization buffer and applied to the array.
 
Hybridization protocol The arrays were hybridized in a GeneChip Hybridization Oven 640 (Affymetrix, Santa Clara, CA) for 16 hours at 45°C, followed by washing, staining with streptavidin-phycoerythrin (SAPE; Molecular Probes, Eugene, OR), signal amplification with biotinylated anti-streptavidin antibody (Vector Labs, Burlingame, CA), and a final staining with SAPE. The staining and washing were performed using two GeneChip Fluidic Station 400s (Affymetrix, Santa Clara, CA) running standard Affymetrix fluidics script.
Scan protocol The distribution of fluorescent material on the processed array was determined using the Agilent G2500 GeneArray Scanner (Agilent Technologies, Santa Clara, CA). The array image scan was processed using Affymetrix Microarray Suite, version 5.0 (MAS 5.0), which resulted in the generation of raw, probe level data in the CEL file format.
Description Gene expression data from Ebola-infected macrophages
Data processing Affymetrix MAS5
 
Submission date Aug 30, 2011
Last update date Jun 14, 2016
Contact name Victor DeFilippis
E-mail(s) [email protected]
Phone 503-418-2757
Organization name Oregon Health and Science University
Department Vaccine and Gene Therapy Institute
Lab DeFilippis
Street address 505 NW 185th Ave.
City Beaverton
State/province OR
ZIP/Postal code 97006
Country USA
 
Platform ID GPL8300
Series (1)
GSE31747 ZEBOV-induced changes in macrophage gene expression
Relations
Reanalyzed by GSE83331

Data table header descriptions
ID_REF
VALUE Signal
ABS_CALL indicating whether the transcript was present (P), absent (A), or marginal (M)
DETECTION P-VALUE

Data table
ID_REF VALUE ABS_CALL DETECTION P-VALUE
AFFX-MurIL2_at 9.80353 A 0.804734
AFFX-MurIL10_at 39.5524 A 0.382599
AFFX-MurIL4_at 16.4002 A 0.354453
AFFX-MurFAS_at 23.6664 A 0.195266
AFFX-BioB-5_at 126.402 P 0.0726999
AFFX-BioB-M_at 124.337 P 0.00227496
AFFX-BioB-3_at 60.7602 P 0.0584438
AFFX-BioC-5_at 297.63 P 0.000581214
AFFX-BioC-3_at 202.578 P 0.000445901
AFFX-BioDn-5_at 273.473 P 0.00141043
AFFX-BioDn-3_at 1876.49 P 0.000389797
AFFX-CreX-5_at 3297.47 P 4.42873e-05
AFFX-CreX-3_at 5374.5 P 4.42873e-05
AFFX-BioB-5_st 37.5353 A 0.216524
AFFX-BioB-M_st 10.4606 A 0.58862
AFFX-BioB-3_st 13.3494 A 0.852061
AFFX-BioC-5_st 11.8293 A 0.852061
AFFX-BioC-3_st 7.81739 A 0.645547
AFFX-BioDn-5_st 13.5064 A 0.574038
AFFX-BioDn-3_st 33.3571 A 0.425962

Total number of rows: 12625

Table truncated, full table size 358 Kbytes.




Supplementary file Size Download File type/resource
GSM787941.CEL.gz 1.9 Mb (ftp)(http) CEL
GSM787941.CHP.gz 4.9 Mb (ftp)(http) CHP
Processed data included within Sample table
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap